Clinical prediction rule for bacteremia with pyelonephritis and hospitalization judgment: chi-square automatic interaction detector (CHAID) decision tree analysis model.


Journal

The Journal of international medical research
ISSN: 1473-2300
Titre abrégé: J Int Med Res
Pays: England
ID NLM: 0346411

Informations de publication

Date de publication:
Jan 2022
Historique:
entrez: 6 1 2022
pubmed: 7 1 2022
medline: 8 1 2022
Statut: ppublish

Résumé

This study was performed to identify predictive factors for bacteremia among patients with pyelonephritis using a chi-square automatic interaction detector (CHAID) decision tree analysis model. This retrospective cross-sectional survey was performed at Juntendo University Nerima Hospital, Tokyo, Japan and included all patients with pyelonephritis from whom blood cultures were taken. At the time of blood culture sample collection, clinical information was extracted from the patients' medical charts, including vital signs, symptoms, laboratory data, and culture results. Factors potentially predictive of bacteremia among patients with pyelonephritis were analyzed using Student's In total, 198 patients (60 (30.3%) men, 138 (69.7%) women; mean age, 74.69 ± 15.27 years) were included in this study, of whom 92 (46.4%) had positive blood culture results. The CHAID decision tree analysis revealed that patients with a white blood cell count of >21,000/μL had a very high risk (89.5%) of developing bacteremia. Patients with a white blood cell count of ≤21,000/μL plus chills plus an aspartate aminotransferase concentration of >19 IU/L constituted the high-risk group (69.0%). The present results are extremely useful for predicting the results of bacteremia among patients with pyelonephritis.

Identifiants

pubmed: 34986702
doi: 10.1177/03000605211065658
pmc: PMC8743944
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3000605211065658

Références

Q J Med. 1987 Mar;62(239):195-220
pubmed: 3116595
Clin Microbiol Infect. 1997 Jun;3(3):306-316
pubmed: 11864125
Infection. 1998 Jul-Aug;26(4):213-21
pubmed: 9717678
Crit Care. 2006;10(2):R63
pubmed: 16635270
Br J Hosp Med. 1993 Mar 3-16;49(5):346-50
pubmed: 8472086
S Afr Med J. 1982 Mar 20;61(12):432-4
pubmed: 7064018
Am J Kidney Dis. 1991 Jan;17(1):1-9
pubmed: 1670905
Q J Med. 1987 May;63(241):427-40
pubmed: 3310074
BMJ Open. 2016 Jul 07;6(7):e010527
pubmed: 27388348
J Infect Dis. 1997 Dec;176(6):1538-51
pubmed: 9395366
Radiology. 1983 Sep;148(3):839-43
pubmed: 6878708
Crit Care Med. 2004 May;32(5):1166-9
pubmed: 15190968
Am Fam Physician. 2005 Mar 1;71(5):933-42
pubmed: 15768623
Eur J Intern Med. 2014 Dec;25(10):914-8
pubmed: 25459214
J Antimicrob Chemother. 2006 Apr;57(4):780-3
pubmed: 16492721
Intern Med. 2018 May 15;57(10):1399-1403
pubmed: 29321419
Int J Cardiol. 2013 Feb 20;163(2):149-56
pubmed: 21726908
Am J Geriatr Psychiatry. 2013 Oct;21(10):957-62
pubmed: 23567433
Clin Infect Dis. 2011 Mar 1;52(5):e103-20
pubmed: 21292654
Ned Tijdschr Geneeskd. 2002 Jan 19;146(3):116-20
pubmed: 11826671
Biol Psychiatry. 1992 Sep 1;32(5):426-37
pubmed: 1486148
Rev Infect Dis. 1991 Jan-Feb;13(1):34-46
pubmed: 2017629
Infect Control Hosp Epidemiol. 1995 Apr;16(4):203-9
pubmed: 7636167
Am J Med. 2005 Dec;118(12):1417
pubmed: 16378800
JAMA. 2017 Jan 17;317(3):301-308
pubmed: 28114554
Can J Urol. 2001 Jun;8 Suppl 1:29-38
pubmed: 11442995
Clin Nutr. 2017 Feb;36(1):11-48
pubmed: 27637832
QJM. 2005 Nov;98(11):813-20
pubmed: 16174688
J Infect. 2011 Feb;62(2):159-64
pubmed: 21055417
Lancet. 1998 Aug 1;352(9125):374
pubmed: 9717936
Johns Hopkins Med J. 1981 Nov;149(5):175-8
pubmed: 7311256
Lancet Infect Dis. 2007 Mar;7(3):210-7
pubmed: 17317602
Ann Intern Med. 2018 Feb 20;168(4):266-275
pubmed: 29404582
Int J Mol Sci. 2021 Apr 26;22(9):
pubmed: 33925831
Crit Care Med. 2018 Dec;46(12):1923-1933
pubmed: 30130262
Thorax. 2004 May;59(5):364-6
pubmed: 15115857
Methods Inf Med. 1993 Apr;32(2):161-6
pubmed: 8321134
Nutrition. 2002 Feb;18(2):199-200
pubmed: 11844655

Auteurs

Sayato Fukui (S)

Department of General Medicine, Juntendo University School of Medicine, Tokyo, Japan.

Akihiro Inui (A)

Department of General Medicine, Juntendo University School of Medicine, Tokyo, Japan.

Mizue Saita (M)

Department of General Medicine, Juntendo University School of Medicine, Tokyo, Japan.

Daiki Kobayashi (D)

Department of Internal Medicine, St. Luke's International Hospital, Tokyo, Japan.

Toshio Naito (T)

Department of General Medicine, Juntendo University School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH